Semi-automated quantitative method for detecting the loss of heterozygosity at chromosome 4 in hepatocellular carcinoma;Detection quantitative semi-automatique des pertes d'heterozygotie sur le bras long du chromosome 4 dans les carcinomes hepatocellulaires

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 11, 1999, Pages 1225-1232

  Bluteau, Olivier ^a   Legoix, Patricia ^a   Bayer, Jan ^a   Bioulac Sage, Paulette ^b   Fléjou, Jean François ^c   Capron, Frédérique ^d   Monges, Geneviève ^e   Brechot, Christian ^f   Thomas, Gilles ^a   Laurent Puig, Pierre ^a   Zucman Rossi, Jessica ^a  

^a INSERM   (France)

^b HÔPITAL PELLEGRIN   (France)

^c BEAUJON HOSPITAL   (France)

^d Service d'Anatomie Pathologique   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chromosome 4; Hepatocellular carcinoma; Loss of heterozygosity; Microsatellite marker; Tumor suppressor gene

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 4Q; CHROMOSOME DELETION 4; DISEASE ASSOCIATION; FEMALE; HETEROZYGOSITY LOSS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; TUMOR SUPPRESSOR GENE; CHROMOSOME 4; GENETICS; GENOTYPE; LIVER TUMOR; MIDDLE AGED;

MICROSATELLITE DNA;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENOTYPE; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0033217672     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ezaki T, Kanematsu T, Okamura T, Sonoda T, Sugimachi K. DNA analysis of hepatocellular carcinoma and clinicopathologic implications. Cancer 1988;61:106-9.
2. Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991;67:939-44.
3. Challen C, Guo K, Collier JD, Cavanagh D, Bassendine MF. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinoma. J Hepatol 1992;14:342-6.
4. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:1973-7.
5. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M. p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 1992;52:3220-3.
6. Peng SY, Lai PL, Hsu HC. Amplification of the c-myc gene in human hepatocellular carcinoma : biologic significance. J Formos Med Assoc 1993;92:866-70.
7. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998;95:8847-51.
8. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 1998;58:2524-7.
9. Zhang XK, Huang DP, Qiu DK, Chiu JF. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990;5:909-14.
10. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andren-Sandberg A, et al. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet 1992;58: 191-5.
11. Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P, et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 1997;57:1986-90.
12. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997;14:2927-33.
13. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65.
14. Buecher B, Schmitz A, Lerebours F, Thuille B, Thomas G, Olschwang S. Vers un allélotype de deuxième génération du cancer du côlon. Gastroenterol Clin Biol 1995;19:1004-10.
15. Duriez C, Schmitz A, Fouchet P, Buecher B, Thuille B, Lerebours F, et al. Localisation d'un gène suppresseur de tumeur distale à D22S270 dans les cancers colo-rectaux. Gastroenterol Clin Biol 1997;21:358-64.
16. Magnuson VL, Ally DS, Nylund SJ, Karanjawala ZE, Rayman JB, Knapp JI, et al. Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase : implications for PCR-based genotyping and cloning. Biotechniques 1996;21: 700-9.
17. Hahn M, Matzen SE, Serth J, Pingoud A. Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53. Biotechniques 1995;18:1040-7.
18. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996;56:3331-7.
19. Salvucci M, Lemoine A, Saffroy R, Azoulay D, Lepere B, Gaillard S, et al. Microsatellite instability in European hepatocellular carcinoma. Oncogene 1999;18:181-7.
20. Piao Z, Park C, Lee JS, Yang CH, Choi KY, Kim H. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma. Cancer Lett 1998;122:201-7.
21. Chou YH, Chung KC, Jeng LB, Chen TC, Liaw YF. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett 1998;123:1-6.
22. Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 1997;14:369-3.
23. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, et al. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997;75:79-86.
24. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ. Allelotype analysis of esophageal adenocarcinomas : evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996;56:4499-502.
25. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54: 4481-7.